Aberrant GLUT-1 expression, which may be an early event in the malignant transformation of the endometrium, provides necessary materials for its overgrowth, enables the tumor cells distant from the mesenchyme to survive, and regulates the onset of endometrial cancer. The gene discussed is SLC2A1; the disease is endometrial cancer.